Oct 21, 2020

Starpharma (ASX:SPL) banks $5.7M government R&D tax refund

The Market Herald reported that Starpharma are to receive a $5.7 million research and development (R&D) tax incentive refund from the Federal Government following the government’s program to  support companies taking on R&D that benefits Australia. To watch the full video click here.

 This contains certain forward-looking statements.